Seer (NASDAQ:SEER) Shares Down 2.7%

Seer, Inc. (NASDAQ:SEER)’s share price was down 2.7% during mid-day trading on Monday . The company traded as low as $1.77 and last traded at $1.79. Approximately 1,043,092 shares traded hands during mid-day trading, an increase of 131% from the average daily volume of 451,460 shares. The stock had previously closed at $1.84.

Wall Street Analyst Weigh In

Separately, Morgan Stanley restated an “equal weight” rating and issued a $7.00 target price on shares of Seer in a report on Tuesday, March 5th.

Seer Price Performance

The stock has a market capitalization of $115.94 million, a price-to-earnings ratio of -1.32 and a beta of 1.65. The business’s 50-day simple moving average is $1.81 and its two-hundred day simple moving average is $1.79.

Seer (NASDAQ:SEER) last announced its quarterly earnings results on Thursday, February 29th. The company reported ($0.28) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.07. The firm had revenue of $4.44 million for the quarter, compared to analysts’ expectations of $4.24 million. Seer had a negative net margin of 517.84% and a negative return on equity of 20.87%. As a group, sell-side analysts expect that Seer, Inc. will post -1.22 EPS for the current year.

Insider Transactions at Seer

In related news, CEO Omid Farokhzad sold 52,857 shares of the company’s stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $2.03, for a total value of $107,299.71. Following the sale, the chief executive officer now directly owns 1,436,285 shares of the company’s stock, valued at $2,915,658.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last three months, insiders have sold 69,149 shares of company stock valued at $133,366. Corporate insiders own 15.02% of the company’s stock.

Institutional Trading of Seer

Several institutional investors have recently added to or reduced their stakes in SEER. Softbank Group CORP. bought a new stake in Seer during the first quarter valued at $19,823,000. Capital World Investors grew its position in shares of Seer by 58.4% during the first quarter. Capital World Investors now owns 2,170,000 shares of the company’s stock worth $33,071,000 after acquiring an additional 800,000 shares during the last quarter. BlackRock Inc. grew its position in shares of Seer by 18.3% during the first quarter. BlackRock Inc. now owns 4,902,002 shares of the company’s stock worth $18,922,000 after acquiring an additional 758,752 shares during the last quarter. State Street Corp grew its position in shares of Seer by 29.8% during the second quarter. State Street Corp now owns 1,472,056 shares of the company’s stock worth $13,175,000 after acquiring an additional 337,801 shares during the last quarter. Finally, Bridgeway Capital Management LLC grew its position in shares of Seer by 292.6% during the fourth quarter. Bridgeway Capital Management LLC now owns 405,143 shares of the company’s stock worth $786,000 after acquiring an additional 301,943 shares during the last quarter. Institutional investors own 75.20% of the company’s stock.

Seer Company Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.